Number,

Medicine, 

Longevity.

We deliver high-accuracy AI-based predictions of clinical trial outcomes for all diseases.

 

We offer clinical-efficacy-prediction-based valuation of biopharma assets for all companies.

Sign up now to receive alerts of our upcoming clinical predictions!

Demiurge has achieved 85% (40/47) accuracy in our 

prospective predictions of the phase 2 and phase 3 clinical trial results in 2020.

as of 30 September 2020

85%

Demiurge's prediction accuracy has beaten the weighted benchmark by a wide margin of +40%.   

+40%

as of 30 September 2020

Demiurge
Weighted
Benchmark
45%
85%
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
Prediction Accuracy

INDICATIONS

78

 Demiurge has made 150+ perspective predictions  covering 78 indications in 16 therapeutic areas. 

as of 30 September 2020

16

THERAPEUTIC ARES

logo front page.png

© 2015-2020 by Demiurge Technologies AG. All Rights Reserved.